GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regen BioPharma Inc (OTCPK:RGBP) » Definitions » E10

Regen BioPharma (Regen BioPharma) E10 : $-34.58 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Regen BioPharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Regen BioPharma's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-34.58 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-14), Regen BioPharma's current stock price is $1.0775. Regen BioPharma's E10 for the quarter that ended in Mar. 2024 was $-34.58. Regen BioPharma's Shiller PE Ratio of today is .


Regen BioPharma E10 Historical Data

The historical data trend for Regen BioPharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regen BioPharma E10 Chart

Regen BioPharma Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -35.56

Regen BioPharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.58 -35.69 -35.56 -34.66 -34.58

Competitive Comparison of Regen BioPharma's E10

For the Biotechnology subindustry, Regen BioPharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regen BioPharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's Shiller PE Ratio falls into.



Regen BioPharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Regen BioPharma's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.03/131.7762*131.7762
=-0.030

Current CPI (Mar. 2024) = 131.7762.

Regen BioPharma Quarterly Data

per share eps CPI Adj_EPS
201406 -4.798 100.560 -6.287
201409 -5.624 100.428 -7.380
201412 -6.300 99.070 -8.380
201503 -13.200 99.621 -17.461
201506 -11.250 100.684 -14.724
201509 -5.850 100.392 -7.679
201512 -8.378 99.792 -11.063
201603 -8.700 100.470 -11.411
201606 -11.700 101.688 -15.162
201609 -10.800 101.861 -13.972
201612 -5.850 101.863 -7.568
201703 -13.950 102.862 -17.871
201706 -28.500 103.349 -36.339
201709 -14.550 104.136 -18.412
201712 -29.250 104.011 -37.058
201803 -11.700 105.290 -14.643
201806 -1.050 106.317 -1.301
201809 -8.700 106.507 -10.764
201812 1.050 105.998 1.305
201903 -1.650 107.251 -2.027
201906 -77.100 108.070 -94.013
201909 4.693 108.329 5.709
201912 4.500 108.420 5.469
202003 -3.900 108.902 -4.719
202006 2.400 108.767 2.908
202009 1.050 109.815 1.260
202012 1.175 109.897 1.409
202103 0.300 111.754 0.354
202106 -3.150 114.631 -3.621
202109 -0.375 115.734 -0.427
202112 1.500 117.630 1.680
202203 -22.040 121.301 -23.943
202206 19.110 125.017 20.143
202209 -0.010 125.227 -0.011
202212 0.450 125.222 0.474
202303 -0.030 127.348 -0.031
202306 -0.030 128.729 -0.031
202309 -0.100 129.860 -0.101
202312 -0.100 129.419 -0.102
202403 -0.030 131.776 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Regen BioPharma  (OTCPK:RGBP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Regen BioPharma E10 Related Terms

Thank you for viewing the detailed overview of Regen BioPharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Regen BioPharma (Regen BioPharma) Business Description

Traded in Other Exchanges
Address
4700 Spring Street, Suite 304, La Mesa, CA, USA, 91942
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.